485 related articles for article (PubMed ID: 32630050)
1. Nonsense Suppression Therapy: New Hypothesis for the Treatment of Inherited Bone Marrow Failure Syndromes.
Bezzerri V; Api M; Allegri M; Fabrizzi B; Corey SJ; Cipolli M
Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32630050
[TBL] [Abstract][Full Text] [Related]
2. Classical inherited bone marrow failure syndromes with high risk for myelodysplastic syndrome and acute myelogenous leukemia.
Savage SA; Dufour C
Semin Hematol; 2017 Apr; 54(2):105-114. PubMed ID: 28637614
[TBL] [Abstract][Full Text] [Related]
3. Inherited bone marrow failure syndromes: phenotype as a tool for early diagnostic suspicion at a major reference center in Mexico.
Leal-Anaya P; Kimball TN; Yanez-Felix AL; Fiesco-Roa MÓ; García-de Teresa B; Monsiváis A; Juárez-Velázquez R; Lieberman E; Villarroel C; Yokoyama E; Fernández-Hernández L; Rivera-Osorio A; Sosa D; Ortiz Sandoval MM; López-Santiago N; Frías S; Del Castillo V; Rodríguez A
Front Genet; 2023; 14():1293929. PubMed ID: 38327701
[No Abstract] [Full Text] [Related]
4. Genomic characterization of the inherited bone marrow failure syndromes.
Khincha PP; Savage SA
Semin Hematol; 2013 Oct; 50(4):333-47. PubMed ID: 24246701
[TBL] [Abstract][Full Text] [Related]
5. Ataluren-driven restoration of Shwachman-Bodian-Diamond syndrome protein function in Shwachman-Diamond syndrome bone marrow cells.
Bezzerri V; Bardelli D; Morini J; Vella A; Cesaro S; Sorio C; Biondi A; Danesino C; Farruggia P; Assael BM; D'amico G; Cipolli M
Am J Hematol; 2018 Aug; 93(4):527-536. PubMed ID: 29285795
[TBL] [Abstract][Full Text] [Related]
6. The Molecular and Genetic Mechanisms of Inherited Bone Marrow Failure Syndromes: The Role of Inflammatory Cytokines in Their Pathogenesis.
Kawashima N; Bezzerri V; Corey SJ
Biomolecules; 2023 Aug; 13(8):. PubMed ID: 37627314
[TBL] [Abstract][Full Text] [Related]
7. Genetics and genomics of bone marrow failure syndrome.
Kim HY; Kim HJ; Kim SH
Blood Res; 2022 Apr; 57(S1):86-92. PubMed ID: 35483932
[TBL] [Abstract][Full Text] [Related]
8. Malignancies and survival patterns in the National Cancer Institute inherited bone marrow failure syndromes cohort study.
Alter BP; Giri N; Savage SA; Peters JA; Loud JT; Leathwood L; Carr AG; Greene MH; Rosenberg PS
Br J Haematol; 2010 Jul; 150(2):179-88. PubMed ID: 20507306
[TBL] [Abstract][Full Text] [Related]
9. Novel Translational Read-through-Inducing Drugs as a Therapeutic Option for Shwachman-Diamond Syndrome.
Bezzerri V; Lentini L; Api M; Busilacchi EM; Cavalieri V; Pomilio A; Diomede F; Pegoraro A; Cesaro S; Poloni A; Pace A; Trubiani O; Lippi G; Pibiri I; Cipolli M
Biomedicines; 2022 Apr; 10(4):. PubMed ID: 35453634
[TBL] [Abstract][Full Text] [Related]
10. [Bone marrow failure and TP53 activating mutations].
Ito E
Rinsho Ketsueki; 2022; 63(9):1115-1125. PubMed ID: 36198537
[TBL] [Abstract][Full Text] [Related]
11. The genomics of inherited bone marrow failure: from mechanism to the clinic.
Wegman-Ostrosky T; Savage SA
Br J Haematol; 2017 May; 177(4):526-542. PubMed ID: 28211564
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of somatic transformation in inherited bone marrow failure syndromes.
Choijilsuren HB; Park Y; Jung M
Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):390-398. PubMed ID: 34889377
[TBL] [Abstract][Full Text] [Related]
13. Cytogenetics in the management of bone marrow failure syndromes: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH).
Cuccuini W; Collonge-Rame MA; Auger N; Douet-Guilbert N; Coster L; Lafage-Pochitaloff M
Curr Res Transl Med; 2023; 71(4):103423. PubMed ID: 38016422
[TBL] [Abstract][Full Text] [Related]
14. [New insights into inherited bone marrow failure syndrome].
Ito E; Toki T; Kamio T; Terui K
Rinsho Ketsueki; 2021; 62(10):1455-1464. PubMed ID: 34732617
[TBL] [Abstract][Full Text] [Related]
15. Posttransplant complications in patients with marrow failure syndromes: are we improving long-term outcomes?
Hudda Z; Myers KC
Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):141-148. PubMed ID: 38066882
[TBL] [Abstract][Full Text] [Related]
16. Otologic manifestations of Fanconi anemia and other inherited bone marrow failure syndromes.
Kalejaiye A; Giri N; Brewer CC; Zalewski CK; King KA; Adams CD; Rosenberg PS; Kim HJ; Alter BP
Pediatr Blood Cancer; 2016 Dec; 63(12):2139-2145. PubMed ID: 27428025
[TBL] [Abstract][Full Text] [Related]
17. Special pre- and posttransplant considerations in inherited bone marrow failure and hematopoietic malignancy predisposition syndromes.
Bonfim C
Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):107-114. PubMed ID: 33275667
[TBL] [Abstract][Full Text] [Related]
18. Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Cell Transplantation for Inherited Bone Marrow Failure Syndromes: Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation.
Dietz AC; Mehta PA; Vlachos A; Savage SA; Bresters D; Tolar J; Boulad F; Dalle JH; Bonfim C; de la Fuente J; Duncan CN; Baker KS; Pulsipher MA; Lipton JM; Wagner JE; Alter BP
Biol Blood Marrow Transplant; 2017 May; 23(5):726-735. PubMed ID: 28115275
[TBL] [Abstract][Full Text] [Related]
19. Ataluren improves myelopoiesis and neutrophil chemotaxis by restoring ribosome biogenesis and reducing p53 levels in Shwachman-Diamond syndrome cells.
Cipolli M; Boni C; Penzo M; Villa I; Bolamperti S; Baldisseri E; Frattini A; Porta G; Api M; Selicato N; Roccia P; Pollutri D; Marinelli Busilacchi E; Poloni A; Caporelli N; D'Amico G; Pegoraro A; Cesaro S; Oyarbide U; Vella A; Lippi G; Corey SJ; Valli R; Polini A; Bezzerri V
Br J Haematol; 2024 Jan; 204(1):292-305. PubMed ID: 37876306
[TBL] [Abstract][Full Text] [Related]
20. [Recent advances in inherited bone marrow failure syndrome research].
Ito E; Toki T; Terui K
Rinsho Ketsueki; 2016 Jul; 57(7):882-90. PubMed ID: 27498735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
